长期过量饮酒对舒芬太尼抑制气管插管时心血管反应ED50的影响
本文关键词: 长期过量饮酒 舒芬太尼 剂量效应关系 气管插管 出处:《福建医科大学》2014年硕士论文 论文类型:学位论文
【摘要】:目的:拟通过测定长期过量饮酒对舒芬太尼抑制气管插管时心血管反应ED50的影响,从而评价长期过量饮酒对舒芬太尼效力的影响。 方法:择期拟行全麻手术的成年男性患者,BMI18~25kg/m2,年龄25~55岁,ASA分级Ⅰ~Ⅱ级纳入本研究。根据世界卫生组织(WHO)对长期过量饮酒的定义将手术患者分为长期过量饮酒组(D组,n=19)和非饮酒组(N组,,n=22)。D组和N组分别先静脉注射丙泊酚2.0~3.0mg/kg(45s),维持脑状态指数(CSI)值40~55,继而静脉注射顺阿曲库铵0.2mg/kg,按预设剂量静注舒芬太尼,5min后行气管插管。监测麻醉诱导前(T0基础值),插管前即刻(T1),插管后1min(T2),插管后5min(T3)血压心率和CSI的变化。按改良序贯法,舒芬太尼的第一个剂量是预实验中出现阴性反应的剂量,D组和N组初始舒芬太尼剂量分别为0.5ug/kg和0.4ug/kg,若患者反应为阳性(气管插管后MAP或HR超过基础值的15%),则下一例舒芬太尼剂量上调0.1ug/kg,若患者反应为阴性(气管插管后MAP或HR未超过基础值的15%),则下一例舒芬太尼剂量下调0.1ug/kg,重复此过程直至出现6次阴性-阳性转折停止研究。采用序贯法计算舒芬太尼ED50及其95%可信区间CI。 结果:D组和N组在年龄、体重指数、性别构成均无统计学差异(P0.05),两组麻醉诱导前心率、收缩压、舒张压、CSI亦无显著性差异。D组纳入患者均为长期过量饮酒者,均未发现有酒精性疾病及其合并症。D组及N组舒芬太尼抑制气管插管时心血管反应的ED50及其95%可信区间分别为0.41(0.37,0.47)ug/kg和0.30(0.27,0.34)ug/kg,D组ED50高于N组(P0.05)。 结论:长期过量饮酒可增加气管插管时舒芬太尼抑制心血管反应ED50,提示长期过量饮酒降低舒芬太尼抑制应激反应的效力。
[Abstract]:Aim: to evaluate the effect of long-term excessive drinking on the efficacy of sufentanil by measuring the effect of sufentanil on cardiovascular response (ED50) to tracheal intubation. Methods: adult male patients undergoing elective general anesthesia were divided into long-term excessive drinking group according to the World Health Organization (WHO) definition of long-term excessive drinking. Group D and group N were given intravenous injection of propofol 2.0 mg / kg / kg for 45sd respectively, and then intravenous injection of atracurium 0.2 mg / kg / kg for 5 min. The anesthesia was monitored by endotracheal intubation after 5 minutes of intravenous injection of sufentanil (0.2mg 路kg ~ (-1)) in group D (n = 10) and non-drinking group (n = 10), and then administered intravenously by intravenous injection of sufentanil (0.2mg / kg) to monitor anesthesia after 5 minutes of intravenous injection of propofol (2.0 mg / kg 路kg ~ (-1)). The changes of blood pressure and heart rate and CSI were observed immediately before intubation, 1 min after intubation, 5 min after intubation, and 5 min after intubation. The first dose of sufentanil was the initial dose of sufentanil in group D and group N, which were negative in the pretest. If the patient was positive (MAP or HR exceeded 15% of the base value after tracheal intubation), the next one was the first dose of sufentanil in group D and group N, respectively. The dose of sufentanil was increased by 0.1ug-kg. if the patient's response was negative (MAP or HR was not more than 15% of the base value after tracheal intubation), then the next case of sufentanil was down-regulated by 0.1 ug-kg-1 / kg, and repeated this process until six negative-positive turning points stopped the study. Sequential method was used to calculate sufentanil ED50 and its 95% CI. Results there was no significant difference in age, body mass index and sex composition between group D and group N. there was no significant difference in heart rate, systolic blood pressure, diastolic blood pressure and CSI between two groups before anesthesia induction. The ED50 and 95% confidence intervals of sufentanil in group D and group N for inhibiting cardiovascular response to endotracheal intubation were 0.41 ~ 0.37 渭 r / kg and 0.30 ~ 0.27 ~ 0.34 g / kg respectively. The ED50 of group D was higher than that of group N (P 0.05). Conclusion: Long-term excessive drinking can increase the inhibitory effect of sufentanil on cardiovascular response ED50 during tracheal intubation, suggesting that long-term excessive drinking reduces the inhibitory effect of sufentanil on stress response.
【学位授予单位】:福建医科大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:R614
【参考文献】
相关期刊论文 前8条
1 孙永锋;冯春;娄晔;;脑功能状态指数(CSI)在全麻中作为镇痛深度监测的实验研究[J];当代医学;2010年21期
2 郭田生,田群力;酒依赖与内源性阿片系统[J];国外医学.精神病学分册;1996年03期
3 方为;侯俊;林雷;余相地;汤和青;;经鼻纤维支气管镜气管插管时舒芬太尼ED_(50)[J];临床麻醉学杂志;2013年10期
4 郑宏;华玉思;朱素洁;邹田田;杨龙;宣燕;;手术患者术前饮酒与健康状况的流行病学调查[J];中国全科医学;2011年14期
5 杨泉涌;薛富善;许亚超;刘毅;廖旭;张雁鸣;刘建华;;等效小剂量瑞芬太尼和芬太尼对经口气管插管小儿血流动力学反应的比较[J];实用儿科临床杂志;2008年23期
6 李秀敏,邓源;乙醇的中枢神经系统损伤作用[J];中国临床康复;2005年21期
7 马冠生,朱丹红,胡小琪,栾德春,孔灵芝,杨晓光;中国居民饮酒行为现况[J];营养学报;2005年05期
8 ;Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases[J];World Journal of Gastroenterology;2003年02期
本文编号:1539061
本文链接:https://www.wllwen.com/yixuelunwen/mazuiyixuelunwen/1539061.html